3880.HK

Medtide Inc. 3880.HK

3880.HK
Medtide Inc. 1541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 1873.HK
Viva Biotech Holdings 6660.HK
AIM Vaccine Co., Ltd. 2197.HK
Clover Biopharmaceuticals, Ltd. 1515.HK
China Resources Medical Holdings Company Limited 6996.HK
Antengene Corporation Limited 2179.HK
Jiangsu Recbio Technology Co., Ltd. 2561.HK
VISEN Pharmaceuticals 9996.HK
Peijia Medical Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 3880.HK 1541.HK 1873.HK 6660.HK 2197.HK 1515.HK 6996.HK 2179.HK 2561.HK 9996.HK
6M -3.25 % 109.31 % 86.67 % 20.43 % 1 047.96 % -2.01 % 85.39 % -4.98 % -2.93 % 32.90 %
YTD -3.25 % 124.89 % 196.47 % -34.17 % 874.03 % -14.07 % 627.94 % -28.40 % -37.50 % 61.58 %
1Y -3.25 % 95.74 % 173.91 % -41.39 % 581.82 % -10.24 % 489.29 % -22.33 % -37.50 % 57.84 %
3Y -3.25 % -45.85 % 81.29 % -79.64 % 25.70 % -22.62 % 43.06 % -72.79 % -37.50 % -9.04 %
5Y -3.25 % -45.85 % -68.26 % -76.29 % -82.67 % -26.29 % -72.92 % -73.54 % -37.50 % -78.83 %
10Y -3.25 % -45.85 % -42.99 % -76.29 % -82.67 % -75.57 % -72.92 % -73.54 % -37.50 % -76.20 %
From the beginning -3.25 % -45.85 % -42.99 % -76.29 % -82.67 % -65.80 % -72.92 % -73.54 % -37.50 % -76.20 %

Dividend

Viva Biotech Holdings

China Resources Medical Holdings Company Limited